Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-10-22
DOI
10.3389/fonc.2019.01120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Screening for Colorectal Cancer
- (2016) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma
- (2016) Rob J. A. Verhoeven et al. JOURNAL OF VIROLOGY
- Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma
- (2016) Hong Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region
- (2015) Aron R. Marquitz et al. JOURNAL OF VIROLOGY
- New Noncoding Lytic Transcripts Derived from the Epstein-Barr Virus Latency Origin of Replication,oriP, Are Hyperedited, Bind the Paraspeckle Protein, NONO/p54nrb, and Support Viral Lytic Transcription
- (2015) Subing Cao et al. JOURNAL OF VIROLOGY
- Aiolos Promotes Anchorage Independence by Silencing p66Shc Transcription in Cancer Cells
- (2014) Xichuan Li et al. CANCER CELL
- Long Noncoding RNA GAPLINC Regulates CD44-Dependent Cell Invasiveness and Associates with Poor Prognosis of Gastric Cancer
- (2014) Y. Hu et al. CANCER RESEARCH
- Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment
- (2014) Gaohong Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer
- (2014) Michael L Gatza et al. NATURE GENETICS
- Genetics of Epstein–Barr virus microRNAs
- (2014) Olaf Klinke et al. SEMINARS IN CANCER BIOLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial–mesenchymal transition and activation of AKT signaling
- (2012) Xin-Jian Li et al. CARCINOGENESIS
- ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia
- (2012) S. G. Landt et al. GENOME RESEARCH
- Aiolos promotes TH17 differentiation by directly silencing Il2 expression
- (2012) Francisco J Quintana et al. NATURE IMMUNOLOGY
- Classification of Epstein-Barr Virus-Positive Gastric Cancers by Definition of DNA Methylation Epigenotypes
- (2011) K. Matsusaka et al. CANCER RESEARCH
- A Novel Persistence Associated EBV miRNA Expression Profile Is Disrupted in Neoplasia
- (2011) Jin Qiu et al. PLoS Pathogens
- Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications
- (2010) K. Billot et al. BLOOD
- Epstein-Barr virus BART gene expression
- (2009) M. Al-Mozaini et al. JOURNAL OF GENERAL VIROLOGY
- The Aiolos transcription factor is up-regulated in chronic lymphocytic leukemia
- (2008) M. Duhamel et al. BLOOD
- Aberrant Ikaros, Aiolos, and Helios expression in Hodgkin and non-Hodgkin lymphoma
- (2008) M. Antica et al. BLOOD
- Epstein-Barr Virus BART MicroRNAs Are Produced from a Large Intron prior to Splicing
- (2008) R. H. Edwards et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now